Exodus Point Capital Management, LP Neuro Pace Inc Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Neuro Pace Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 19,431 shares of NPCE stock, worth $140,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,431Holding current value
$140,486% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
61Shares Held
18.7MCall Options Held
28.9KPut Options Held
7.5K-
Kck Ltd. Tortola, D85.62MShares$40.6 Million77.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA4MShares$28.9 Million1.19% of portfolio
-
Morgan Stanley New York, NY2.48MShares$18 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$17.6 Million2.63% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT778KShares$5.63 Million0.66% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $180M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...